Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Amortization - Intangibles (2022 - 2025)

Bioregenx has reported Amortization - Intangibles over the past 4 years, most recently at -$25000.0 for Q4 2025.

  • For Q4 2025, Amortization - Intangibles fell 104.45% year-over-year to -$25000.0; the TTM value through Dec 2025 reached $1.1 million, down 49.67%, while the annual FY2024 figure was $2.2 million, N/A changed from the prior year.
  • Amortization - Intangibles for Q4 2025 was -$25000.0 at Bioregenx, down from $562089.0 in the prior quarter.
  • Over five years, Amortization - Intangibles peaked at $562089.0 in Q2 2024 and troughed at -$25000.0 in Q4 2025.
  • A 4-year average of $216645.3 and a median of $1483.0 in 2022 define the central range for Amortization - Intangibles.
  • Biggest five-year swings in Amortization - Intangibles: skyrocketed 33465.14% in 2024 and later crashed 104.45% in 2025.
  • Year by year, Amortization - Intangibles stood at $1483.0 in 2022, then changed by 0.0% to $1483.0 in 2023, then soared by 37802.16% to $562089.0 in 2024, then plummeted by 104.45% to -$25000.0 in 2025.
  • Business Quant data shows Amortization - Intangibles for BRGX at -$25000.0 in Q4 2025, $562089.0 in Q4 2024, and $562089.0 in Q3 2024.